Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2025
DOI: 10.1016/j.saa.2025.126183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2025. Verfasst von Qixin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Apoptosis, Fluorescent Dyes, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: The Affiliated Hospital of Southwest Medical University, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a cancerous tumor that poses a global threat to women's lives and health. Currently, chemotherapy is the preferred treatment for advanced TNBC. In this work, we have identified a novel NIR fluorescent inhibitor, SWMU690, which can effectively inhibit the proliferation of TNBC at low doses. The half-maximal inhibitory concentration (IC50) values of SWMU690 against the MDA-MB-231, 4 T1, and T47D cell lines were determined to be 104 nM, 509.4 nM, and 206 nM, respectively. We found that SWMU690 specifically localized in mitochondria to trigger mitochondria-mediated intrinsic apoptotic pathways. Furthermore, SWMU690 can suppress the production of ATP to inhibit TNBC metastasis. This study demonstrated the advantage of disrupting the function of mitochondria in inhibiting the proliferation and metastasis of TNBC, and may have other applications in the treatment of other malignant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000 Sichuan, China. Electronic address: zqx17313…
- Chengdu University of Traditional Chinese Medicine, Chengdu 610000 Sichuan, China. Electronic address: wujiao@stu.cdutcm.edu.cn.
- Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000 Sichuan, China. Electronic address: 15562470…
- Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000 Sichuan, China; Institute of Integrated Chin…
- Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou 646000, China. Electronic address: lcq-1973@163.com.
Förderung
- The Affiliated Hospital of Southwest Medical University
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Zhao, Q., Wu, J., Yao, J., Liu, Z., Li, C., & Sun, Q. (2025). Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.126183
Vancouver
Zhao Q, Wu J, Yao J, Liu Z, Li C, Sun Q. Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2025. doi:10.1016/j.saa.2025.126183
BibTeX
@article{Zhao2025,
author = {Zhao, Qixin and Wu, Jiao and Yao, Jiale and Liu, Zengjin and Li, Changqiang and Sun, Qin},
title = {Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2025},
doi = {10.1016/j.saa.2025.126183}
}
EUVIMED